يعرض 1 - 10 نتائج من 186 نتيجة بحث عن '"T lymphocyte subset"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  4. 4
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  6. 6

    المساهمون: Ligotti, Mattia Emanuela, Aiello, Anna, Accardi, Giulia, Aprile, Stefano, Bonura, Floriana, Bulati, Matteo, Gervasi, Francesco, Giammanco, Giovanni M, Pojero, Fanny, Zareian, Nahid, Caruso, Calogero, Farzaneh, Farzin, Candore, Giuseppina

    المصدر: Clinical and Experimental Immunology

  7. 7

    المساهمون: Barone M., Mendozzi L., D'amico F., Saresella M., Rampelli S., Piancone F., La Rosa F., Marventano I., Clerici M., D'arma A., Pugnetti L., Rossi V., Candela M., Brigidi P., Turroni S.

    المصدر: International Journal of Molecular Sciences
    International Journal of Molecular Sciences, Vol 22, Iss 7173, p 7173 (2021)
    Volume 22
    Issue 13

    وصف الملف: ELETTRONICO; application/pdf

  8. 8
  9. 9

    المساهمون: Associazione Onlus Il pensatore: Matteo Amitrano, Associazione Italiana Contro le Leucemie - Linfomi e Mieloma, Foundation Corrado, [Ocadlikova,D, Lecciso,M, Cavo,M, Curti,A] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. [Ocadlikova,D, Cavo,M] Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy. [Broto,JM] Virgen del Rocio University Hospital, Institute of Biomedicine Research (IBIS), Seville, Spain. [Scotlandi,K] Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. [Palmerini,E] Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., This study was supported by the Associazione Onlus ‘il Pensatore: Matteo Amitrano’, by Bologna AIL (Associazione Italiana contro le Leucemie), Section of Bologna, FATRO, Foundation Corrado and Bruno Maria Zaini-Bologna, Ocadlikova D., Lecciso M., Broto J.M., Scotlandi K., Cavo M., Curti A., Palmerini E.

    المصدر: Frontiers in Immunology
    Digital.CSIC. Repositorio Institucional del CSIC
    instname
    Frontiers in Immunology, Vol 12 (2021)

    مصطلحات موضوعية: 0301 basic medicine, Sarcoma sinovial, Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [Medical Subject Headings], Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::T-Lymphocyte Subsets::T-Lymphocytes, Regulatory [Medical Subject Headings], Células dendríticas, Programmed Cell Death 1 Receptor, Apoptosis, 178103907) [nivolumab (PubChem SID], Lymphocyte Activation, T-Lymphocytes, Regulatory, T regulatory cells (Tregs), Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, T-Lymphocyte Subsets, Inmunomodulación, Sunitinib, Dendritic cell (DC), Immunology and Allergy, Medicine, Nivolumab (PubChem SID: 178103907), Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::Lymphocyte Subsets::T-Lymphocyte Subsets [Medical Subject Headings], Immune Checkpoint Inhibitors, Original Research, Osteosarcoma, Synovial sarcoma, Phenomena and Processes::Immune System Phenomena::Immune System Processes::Lymphocyte Activation [Medical Subject Headings], medicine.anatomical_structure, Nivolumab, 030220 oncology & carcinogenesis, Sarcoma, Human, medicine.drug, lcsh:Immunologic diseases. Allergy, Linfocitos T reguladores, Immune Checkpoint Inhibitor, T cell, T regulatory cells, Immunology, Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, Differentiation, T-Lymphocyte::Programmed Cell Death 1 Receptor [Medical Subject Headings], Protein Kinase Inhibitor, T-Lymphocyte Subset, Dendritic Cell, Tyrosine kinase inhibitor (TKI), Immunophenotyping, Immunomodulation, 5329102) [sunitinib (PubChem CID], Interferon-gamma, 03 medical and health sciences, Immune system, Phenomena and Processes::Immune System Phenomena::Immune System Processes::Immunomodulation [Medical Subject Headings], Cell Line, Tumor, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Immunologic Techniques::Immunologic Tests::Immunophenotyping [Medical Subject Headings], Humans, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings], Protein Kinase Inhibitors, Cell Proliferation, Anatomy::Cells::Antigen-Presenting Cells::Dendritic Cells [Medical Subject Headings], business.industry, CD47, Apoptosi, Biomarker, Dendritic Cells, Sunitinib (PubChem CID: 5329102), medicine.disease, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosis [Medical Subject Headings], respiratory tract diseases, 030104 developmental biology, Cell culture, Cancer research, lcsh:RC581-607, business, Biomarkers

    وصف الملف: application/pdf; ELETTRONICO

  10. 10
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.